Lab-free testing moves closer Secures $1.1 Million in Latest Series A Funding Round

Lab-free testing moves closer secured $1.1 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Lab-free testing moves closer Raises $1.1 million in Funding

Lab-free testing moves closer to home as Germany's Intu Diagnostics raises €1.1 million - EU-Startups. Funding Germany-Startups Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million By David Cendon Garcia June 26, 2026 Share Intu Diagnostics, a Liepzig-based startup developing a platform for completely lab-free molecular diagnostics, has closed a €1.1 million strategic bridge round- bringing their total funding secured to over €3 million.

Investors Behind the Funding

The round was backed by investment firm General Atlantic. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Lab-free testing moves closer operates in Healthcare & Life Sciences. Lab-free testing moves closer's financing adds to recent private-market activity.

Strategic Use of Funds

Home as Germany's Intu Diagnostics raises €1.

Looking Ahead

Sovereign intelligence from space is entering a new era, and the window to build it is now,

Source reference: original announcement/article.